IP Verse

Interleukin-13 Antibody Composition - EP1942939

The patent EP1942939 was granted to Medimmune on Jul 7, 2021. The application was originally filed on Sep 29, 2006 under application number EP06794604A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP1942939

MEDIMMUNE
Application Number
EP06794604A
Filing Date
Sep 29, 2006
Status
Patent Maintained As Amended
Jun 12, 2021
Grant Date
Jul 7, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DERMIRAFeb 28, 2019VENNER SHIPLEYWITHDRAWN

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTFR2685919
INTERNATIONAL-SEARCH-REPORTUS2004248260
INTERNATIONAL-SEARCH-REPORTUS2005158316
INTERNATIONAL-SEARCH-REPORTUS5596072
INTERNATIONAL-SEARCH-REPORTWO2004001007
INTERNATIONAL-SEARCH-REPORTWO2005007699
INTERNATIONAL-SEARCH-REPORTWO2005081873
OPPOSITIONCN1563090
OPPOSITIONEP1614693
OPPOSITIONFR2685919
OPPOSITIONUS2004234499
OPPOSITIONUS2004248260
OPPOSITIONUS2005158316
OPPOSITIONUS2006063228
OPPOSITIONUS5596072
OPPOSITIONUS5866154
OPPOSITIONWO0166754
OPPOSITIONWO0207850
OPPOSITIONWO03010512
OPPOSITIONWO2004001007
OPPOSITIONWO2004076485
OPPOSITIONWO2005007699
OPPOSITIONWO2005062967
OPPOSITIONWO2005081873
OPPOSITIONWO2012049287
OPPOSITIONWO9742329
OPPOSITIONWO9964462

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- BOTTOMLEY et al., "Elution of human IgG from affinity columns containing immobilised variants of protein A", Journal of Immunological Methods, (19950000), vol. 182, no. 2, pages 185 - 192-
OPPOSITION- Declaration from Kirsten Gonzalez-
OPPOSITION- Exhibit A-
OPPOSITION- Exhibit B-
OPPOSITION- Exhibit C-
OPPOSITION- GUERRIER et al., "New method for the selective capture antibodies under physiolgical conditions", Bioseparation, (20000000), vol. 9, pages 211 - 221-
OPPOSITION- GUERRIER et al., "New method for the selective capture antibodies under physiolgical conditions", Bioseparation, (20000000), vol. 9, pages 211 - 221, XP055570644-
OPPOSITION- LEIBL et al., "Separation of polysaccharide-specific human immunoglobulin G subclasses using a protein a superose column with a pH gradient elution system", Journal of Chromatography, (19930000), vol. 639, pages 51 - 56-
OPPOSITION- LEIBL et al., "Separation of polysaccharide-specific human immunoglobulin G subclasses using a protein a superose column with a pH gradient elution system", Journal of Chromatography, (19930000), vol. 639, pages 51 - 56, XP002980265
OPPOSITION- BOTTOMLEY et al., "Elution of human IgG from affinity columns containing immobilised variants of protein A", Journal of Immunological Methods, (19950000), vol. 182, no. 2, pages 185 - 192, XP004021167

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents